Nicola Curtin is an English academic. She is Professor of Experimental Cancer Therapeutics at Newcastle University. She is best known for being part of the Newcastle University team that developed Rubraca, a PARP inhibitor used as an anti-cancer agent addressing BRCA mutation, and for donating her share of the royalties to charity.
Provided by Wikipedia